Move log
Jump to navigation
Jump to search
Below is a list of all page moves.
(newest | oldest) View (newer 50 | older 50) (20 | 50 | 100 | 250 | 500)- 21:45, 4 May 2023 Jwarner talk contribs moved page Ensartinib (X-396) to Ensartinib (Ensacove) (Acquired a brand name)
- 20:27, 26 April 2023 Jwarner talk contribs moved page Acquired coagulopathy to Acquired hemophilia A
- 20:17, 5 April 2023 Warner-admin talk contribs moved page Thrombocytopenia to Thrombocytopenia and platelet dysfunction
- 13:39, 2 March 2023 Jwarner talk contribs moved page Rhabdomyosarcoma - historical to Rhabdomyosarcoma, pediatric - historical (This page contains pediatric-specific regimens)
- 16:29, 28 January 2023 Jwarner talk contribs moved page Pirtobrutinib (LOXO-305) to Pirtobrutinib (Jaypirca) (FDA approval)
- 15:57, 28 January 2023 Jwarner talk contribs moved page Elacestrant (RAD1901) to Elacestrant (Orserdu) (FDA approval)
- 12:37, 31 December 2022 Jwarner talk contribs moved page Ropeginterferon alfa-2b (AOP2014) to Ropeginterferon alfa-2b (Besremi) (EMA approval)
- 12:31, 31 December 2022 Jwarner talk contribs moved page Lipefilgrastim (XM22) to Lipefilgrastim (Lonquex) (EMA approval)
- 21:10, 26 December 2022 Jwarner talk contribs moved page Adagrasib (MRTX849) to Adagrasib (Krazati) (FDA approval)
- 12:38, 4 December 2022 Jwarner talk contribs moved page NEOD001 to Birtamimab (NEOD001)
- 12:36, 4 December 2022 Jwarner talk contribs moved page Hu5F9-G4 to Magrolimab (Hu5F9-G4)
- 12:21, 4 December 2022 Jwarner talk contribs moved page AMG 330 to Eluvixtamab (AMG 330)
- 13:52, 3 December 2022 Jwarner talk contribs moved page Acute myeloid leukemia, FLTE3-positive - null regimens to Acute myeloid leukemia, FLT3-positive - null regimens
- 15:40, 7 November 2022 Jwarner talk contribs moved page Teclistamab (JNJ 64007957) to Teclistamab (Tecvayli)
- 10:31, 5 November 2022 Jwarner talk contribs moved page Sutimlimab (BIVV009) to Sutimlimab (Enjaymo) (FDA approval)
- 21:43, 24 October 2022 Jwarner talk contribs moved page Tremelimumab (ticilimumab) to Tremelimumab (Imjudo) (FDA approval)
- 20:52, 9 October 2022 Warner-admin talk contribs moved page Category:Chronic myelogenous leukemia regimens to Category:Chronic myeloid leukemia regimens without leaving a redirect
- 23:36, 26 September 2022 Warner-admin talk contribs moved page Category:Chronic myelogenous leukemia medications (investigational) to Category:Chronic myeloid leukemia medications (investigational) without leaving a redirect
- 23:36, 26 September 2022 Warner-admin talk contribs moved page Category:Chronic myelogenous leukemia medications (historic) to Category:Chronic myeloid leukemia medications (historic)
- 23:36, 26 September 2022 Warner-admin talk contribs moved page Category:Chronic myelogenous leukemia medications to Category:Chronic myeloid leukemia medications without leaving a redirect
- 15:20, 16 September 2022 Warner-admin talk contribs moved page Example orders for Ado-trastuzumab emtansine (Kadcyla) in breast cancer to Example orders for trastuzumab emtansine (Kadcyla) in breast cancer without leaving a redirect
- 14:52, 16 September 2022 Warner-admin talk contribs moved page Ado-trastuzumab emtansine (Kadcyla) to Trastuzumab emtansine (Kadcyla) (simplification)
- 00:33, 8 September 2022 Jwarner talk contribs moved page Chronic myelogenous leukemia - historical to Chronic myeloid leukemia - historical
- 17:34, 6 September 2022 Jwarner talk contribs moved page Pimitespib (TAS-116) to Pimitespib (Jeselhy) (PMDA approval)
- 18:14, 30 August 2022 Jwarner talk contribs moved page Quizartinib (AC220) to Quizartinib (Vanflyta) (PMDA approved)
- 19:52, 25 August 2022 Jwarner talk contribs moved page Chronic myelogenous leukemia, pediatric to Chronic myeloid leukemia, pediatric (Concordance with ICC naming conventions)
- 19:51, 25 August 2022 Jwarner talk contribs moved page Chronic myelogenous leukemia to Chronic myeloid leukemia (Concordance with ICC terminology)
- 10:40, 9 August 2022 Jwarner talk contribs moved page Ewing Sarcoma, pediatric to Ewing sarcoma, pediatric (consistent capitalization)
- 10:35, 9 August 2022 Jwarner talk contribs moved page Ewing Sarcoma - historical to Ewing sarcoma, pediatric - historical
- 14:24, 29 July 2022 Jwarner talk contribs moved page B-cell acute lymphoblastic leukemia, Ph-positive, pediatric to B-cell acute lymphoblastic leukemia, pediatric, Ph-positive
- 23:10, 7 July 2022 Warner-admin talk contribs moved page Mesothelioma - null regimens to Malignant pleural mesothelioma - null regimens without leaving a redirect
- 14:13, 5 May 2022 Jwarner talk contribs moved page Toripalimab (JS001) to Toripalimab (Tuoyi) (NMPA approval)
- 16:24, 1 May 2022 Jwarner talk contribs moved page Malignant Pleural Mesothelioma to Malignant pleural mesothelioma
- 16:12, 1 May 2022 Warner-admin talk contribs moved page Non-small cell lung cancer, Squamous to Non-small cell lung cancer, squamous (Text replacement - "cancer, Squ" to "cancer, squ")
- 16:10, 1 May 2022 Warner-admin talk contribs moved page Non-small cell lung cancer, Nonsquamous to Non-small cell lung cancer, nonsquamous (Text replacement - "cancer, Nonsq" to "cancer, nonsq")
- 16:06, 1 May 2022 Jwarner talk contribs moved page Malignant Peritoneal Mesothelioma to Malignant peritoneal mesothelioma (Capitalization)
- 01:11, 1 May 2022 Jwarner talk contribs moved page Desmoid tumors to Desmoid tumor (Naming convention)
- 01:05, 30 April 2022 Jwarner talk contribs moved page Colon cancer, MSI-H or dMMR to Colorectal cancer, MSI-H or dMMR
- 01:05, 30 April 2022 Jwarner talk contribs moved page Colon cancer, HER2-positive to Colorectal cancer, HER2-positive (Re-organization)
- 01:04, 30 April 2022 Jwarner talk contribs moved page Colon cancer, BRAF-mutated to Colorectal cancer, BRAF-mutated (Re-organization)
- 13:41, 25 April 2022 Jwarner talk contribs moved page Mesothelioma to Malignant Pleural Mesothelioma (creating new peritoneal mesothelioma page)
- 12:10, 22 April 2022 Jwarner talk contribs moved page Sintilimab (IBI 308) to Sintilimab (Tyvyt) (Approval)
- 12:08, 22 April 2022 Jwarner talk contribs moved page Category:CFDA approved drugs to Category:NMPA approved drugs (agency renamed)
- 00:50, 26 March 2022 Jwarner talk contribs moved page Medullary thyroid cancer to Thyroid cancer, medullary (naming convention)
- 00:50, 26 March 2022 Jwarner talk contribs moved page Differentiated thyroid cancer to Thyroid cancer, differentiated (naming convention)
- 00:16, 26 March 2022 Jwarner talk contribs moved page Pacritinib (SB1518) to Pacritinib (Vonjo) (FDA approval)
- 21:00, 24 March 2022 PeterYang talk contribs moved page Lutetium-177-PSMA-617 to Lutetium Lu 177 vipivotide tetraxetan (Pluvicto) (FDA approval)
- 21:53, 22 March 2022 Jwarner talk contribs moved page Relatlimab (BMS-986016) to Nivolumab and relatlimab (Opdualag) (FDA approval)
- 15:11, 3 March 2022 Jwarner talk contribs moved page Ciltacabtagene autoleucel (JNJ-68284528) to Ciltacabtagene autoleucel (Carvykti) (FDA approval)
- 22:28, 27 January 2022 Jwarner talk contribs moved page Tebentafusp (IMCgp100) to Tebentafusp (Kimmtrak) (FDA approval)